Abstract
Objective: To describe a case of clinician of jaw osteonecrosis associated with the use of bisphosphonates, as well as its clinical characteristics and adopted approach. Case Details: A 67-year-old female patient attended the Stomatology service due to the presence of a maxillary lesion. In medical history reported being diabetic and hypertensive, and have been using treatment for osteoporosis for 4 years with Alendronate Sodium. On physical examination, necrotic areas with extensive bone exposure in the maxillary rim were observed. Conservative treatment was initially proposed, with daily mouthwash with 0.12% chlorhexidine and monthly follow-up, as the patient did not report symptoms and did not present bone sequestration. However, five months later, the bone was sequestered, so surgical intervention was necessary. Final Considerations: Jaw osteonecrosis may occur due to prolonged use of bisphosphonates. The correct diagnosis by the dentist is of fundamental importance, reinforcing the orientation to those patients submitted to treatment with this class of drugs, aiming at the prevention of the disease.